Published in N Engl J Med on January 17, 2002
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child (2004) 2.54
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol (2009) 2.26
Are hepatitis B virus and celiac disease linked? Hepat Mon (2010) 2.10
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
Small bowel neoplasia in coeliac disease. Gut (2003) 1.73
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int (2008) 1.62
Quality characteristics of gluten free cookies prepared from different flour combinations. J Food Sci Technol (2011) 1.56
Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol (2011) 1.52
Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol (2006) 1.51
Changing presentation of adult celiac disease. Dig Dis Sci (2003) 1.44
Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci (2003) 1.41
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol (2009) 1.25
Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr (2008) 1.24
HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol (2007) 1.22
Cutaneous manifestations in celiac disease. World J Gastroenterol (2006) 1.16
Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci (2005) 1.14
A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol (2010) 1.14
The gluten-free diet: safety and nutritional quality. Nutrients (2010) 1.13
Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci (2007) 1.12
Physician awareness of celiac disease: a need for further education. J Gen Intern Med (2005) 1.08
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles. J Med Chem (2006) 1.07
Celiac disease. Orphanet J Rare Dis (2006) 1.05
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol (2012) 1.05
Prevalence of celiac disease among symptom-free children from the Eastern Province of Saudi Arabia. Saudi J Gastroenterol (2015) 1.04
Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas. Int J Pediatr Endocrinol (2010) 1.04
Celiac disease: diagnostic criteria in progress. Cell Mol Immunol (2011) 1.04
Pericardial effusion in celiac disease. Int J Prev Med (2014) 1.03
Clinical presentation of celiac disease and the diagnostic accuracy of serologic markers in children. Eur J Pediatr (2008) 1.00
Multiple immune disorders in unrecognized celiac disease: a case report. World J Gastroenterol (2003) 1.00
Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am (2008) 0.99
Gluten contamination in the Canadian commercial oat supply. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.99
Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus. Dig Dis Sci (2011) 0.98
Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol (2014) 0.98
Intestinal obstruction in celiac disease: case report. Dig Dis Sci (2004) 0.97
Celiac disease in South-West of Iran. World J Gastroenterol (2006) 0.97
Neurological abnormalities associated with celiac disease. J Neurol (2004) 0.93
Autism and coeliac disease. J Autism Dev Disord (2007) 0.92
Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients. Clin Diagn Lab Immunol (2005) 0.92
Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut (2004) 0.91
Immunologic endocrine disorders. J Allergy Clin Immunol (2010) 0.91
Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol (2008) 0.90
Prevalence of silent celiac disease in patients with dyspepsia. Dig Dis Sci (2007) 0.90
Celiac disease prevalence in Brazilian dilated cardiomyopathy patients. Dig Dis Sci (2006) 0.89
Methotrexate induced sprue-like syndrome. World J Gastroenterol (2008) 0.89
Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease. BMC Gastroenterol (2011) 0.89
Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirão Preto, State of São Paulo, Brazil. Dig Dis Sci (2006) 0.89
Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics (2012) 0.88
Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diagn Lab Immunol (2005) 0.88
Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc (2005) 0.88
Gluten intolerance: sex and age-related features. Can J Gastroenterol (2006) 0.87
Prevalence of celiac disease in Shiraz, southern Iran. Saudi J Gastroenterol (2008) 0.87
Serologic celiac disease in patients with inflammatory bowel disease. J Res Med Sci (2012) 0.86
Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA. World J Gastroenterol (2009) 0.86
2013 update on celiac disease and eosinophilic esophagitis. Nutrients (2013) 0.86
Celiac disease in the Turkish population. Dig Dis Sci (2005) 0.86
Celiac disease is not associated with chronic hepatitis C. Dig Dis Sci (2007) 0.86
Serological and clinical comparison of children and adults with anti-endomysial antibodies. J Clin Immunol (2007) 0.86
Management of Enteropathy-Associated T-Cell Lymphoma: An Algorithmic Approach. Case Rep Oncol (2009) 0.86
Medical nutrition therapy: use of sourdough lactic acid bacteria as a cell factory for delivering functional biomolecules and food ingredients in gluten free bread. Microb Cell Fact (2011) 0.85
Age related clinical features of childhood coeliac disease in Australia. BMC Pediatr (2005) 0.84
Serologic testing for celiac disease in young adults--a cost-effect analysis. Dig Dis Sci (2005) 0.84
Peripheral Neuropathy and Celiac Disease. Curr Treat Options Neurol (2005) 0.83
Subclinical cardiac dysfunction in children with coeliac disease: is the gluten-free diet effective? ISRN Gastroenterol (2012) 0.83
Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease. Clin Exp Immunol (2007) 0.83
Association between celiac disease and iron deficiency in Caucasians, but not non-Caucasians. Clin Gastroenterol Hepatol (2013) 0.83
The association between celiac disease and eosinophilic esophagitis in children and adults. BMC Gastroenterol (2013) 0.82
Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease. Dig Dis Sci (2007) 0.82
Protein-protein interaction network of celiac disease. Gastroenterol Hepatol Bed Bench (2016) 0.82
An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int (2014) 0.82
Isolated short stature as a presentation of celiac disease in Saudi children. Pediatr Rep (2010) 0.81
Occult celiac disease prevents penetrance of hemochromatosis. World J Gastroenterol (2005) 0.81
Coeliac disease in an adult presenting as intussusception without a lead point. BMJ Case Rep (2014) 0.81
Celiac disease and persistent symptoms. Clin Gastroenterol Hepatol (2010) 0.81
Animal models to study gluten sensitivity. Semin Immunopathol (2012) 0.80
Clinical pearls in gastroenterology. Mayo Clin Proc (2009) 0.80
Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population. Int J Med Sci (2014) 0.80
Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol (2004) 0.79
Celiac disease: an underappreciated issue in women’s health. Womens Health (Lond Engl) (2010) 0.79
Idiopathic chronic urticaria and celiac disease. Dig Dis Sci (2005) 0.79
Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population. World J Gastroenterol (2007) 0.79
Correlation of tissue transglutaminase antibody with duodenal histologic marsh grading. Middle East J Dig Dis (2014) 0.79
Stroke and dilated cardiomyopathy associated with celiac disease. World J Gastroenterol (2010) 0.79
Frequency of celiac disease in adult patients with typical or atypical malabsorption symptoms in isfahan, iran. Gastroenterol Res Pract (2012) 0.79
Celiac disease: Serologic prevalence in patients with irritable bowel syndrome. J Res Med Sci (2012) 0.79
Antigliadin antibody in an ataxic patient with no other evidence of celiac sprue. Gastroenterol Hepatol (N Y) (2007) 0.78
Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran. Int J Diabetes Dev Ctries (2008) 0.78
Prevalence of celiac disease in children with idiopathic dilated cardiomyopathy. Iran J Pediatr (2014) 0.78
The concentration of serum zinc in celiac patients compared to healthy subjects in Tehran. Gastroenterol Hepatol Bed Bench (2013) 0.78
Cardiomyopathy associated with celiac disease in childhood. Case Rep Gastrointest Med (2012) 0.78
Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J Neurol Neurosurg Psychiatry (2005) 0.78
Novel trends in celiac disease. Cell Mol Immunol (2011) 0.78
Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease. Mucosal Immunol (2010) 0.78
Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach. Dig Dis Sci (2003) 0.77
Midaortic syndrome and celiac disease: a case of local vasculitis. Clin Rheumatol (2004) 0.77
The role of ultrasonography in patients with celiac disease. World J Gastroenterol (2006) 0.77
Coagulopathy due to celiac disease presenting as intramuscular hemorrhage. J Gen Intern Med (2007) 0.77
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis (2001) 6.92
Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
A mouse model of Clostridium difficile-associated disease. Gastroenterology (2008) 3.65
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis (2007) 3.15
Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology (2008) 2.50
Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol (2002) 1.94
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). Vaccine (2009) 1.85
Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease. Clin Gastroenterol Hepatol (2007) 1.70
Microscopic colitis. Gastroenterology (2011) 1.66
Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology (2005) 1.62
Fecal microbiota transplantation--an old therapy comes of age. N Engl J Med (2013) 1.50
Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile. J Mol Diagn (2008) 1.41
Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut (2012) 1.37
Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun (2006) 1.26
Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J Biol Chem (2006) 1.25
Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun (2003) 1.18
Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis (2013) 1.09
Human antibody response to surface layer proteins in Clostridium difficile infection. FEMS Immunol Med Microbiol (2004) 1.06
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters. Antimicrob Agents Chemother (2008) 1.05
MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.00
Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis. Am J Physiol Gastrointest Liver Physiol (2005) 0.99
Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am J Physiol Gastrointest Liver Physiol (2007) 0.95
Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice. Gastroenterology (2009) 0.90
Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses. J Med Microbiol (2013) 0.90
A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection. Clin Gastroenterol Hepatol (2008) 0.90
Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes. Antimicrob Agents Chemother (2013) 0.89
Refractory celiac disease. Curr Gastroenterol Rep (2007) 0.88
Update on the immunologic basis of Helicobacter pylori gastritis. Curr Opin Gastroenterol (2004) 0.88
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile. Antimicrob Agents Chemother (2012) 0.85
Celiac disease and gastroesophageal reflux disease: yet another presentation for a clinical chameleon. Clin Gastroenterol Hepatol (2010) 0.83
Gastrointestinal cancer in celiac disease: "the first days are the hardest days, don't you worry anymore?". Clin Gastroenterol Hepatol (2011) 0.81
Quantifying gastric Helicobacter pylori infection: a comparison of quantitative culture, urease breath testing, and histology. Dig Dis Sci (2007) 0.78
Celiac sprue. Semin Gastrointest Dis (2002) 0.78
Is duodenal biopsy required in all patients with suspected celiac disease? Nat Clin Pract Gastroenterol Hepatol (2007) 0.75
Aspects of large intestinal health and disease. Curr Opin Gastroenterol (2013) 0.75
Large intestine. Curr Opin Gastroenterol (2012) 0.75
Socioeconomic Risk Factors for Celiac Disease Burden and Symptoms. J Clin Gastroenterol (2016) 0.75
Large intestine. Curr Opin Gastroenterol (2011) 0.75
Reflux, dyspepsia, and disorders of the foregut. South Med J (2007) 0.75